Cyberounds Logo
September 23, 2020 | LOGIN | REGISTER | HELP | 

email a friend print Bookmark and Share
Does Transcatheter Laser Myocardial Revascularization Have a Potential Role in the Treatment of Patients with Refractory Angina Who Are Not Considered Candidates for PTCA or CABG?
CME credit is no longer available for this conference.
Ran Kornowski, M.D. and Martin B. Leon, M.D.

Drs. Kornowski and Leon are from the Cardiology Research Foundation, Washington Hospital Center, Washington, DC, USA.

Drs. Kornowski and Leon report no commercial conflict of interest.

Release Date: 07/23/1998
Termination Date: 07/23/2001

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Learning Objectives
Upon completion of this Cyberounds®, you should be able to:
  • Understand the theoretical basis for the benefit achieved by creating laser cut channels in ischemic myocardium
  • Discuss both the surgical approaches and percutaneous approaches to TMR
  • Understand the criteria for determining potential patient candidates for TMR trials.

This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
Please click below to accept the terms of this CME activity